Abstract
Our objective was to evaluate the prevalence of autoantibodies to cyclic citrullinated peptides (anti-CCP aAbs) in a cohort of patients with a variety of inflammatory or non-inflammatory rheumatic diseases other than rheumatoid arthritis (RA). Six hundred and nine serum samples were tested for anti-CCP aAbs and for rheumatoid factor (RF) using enzyme-linked immunosorbent assays and immunonephelometry. The prevalence of anti-CCP aAbs and RF reached 10% and 25%, respectively, using the positive cutoff value suggested by the manufacturers. Using a higher cutoff value (50 U/ml) for both aAbs, the prevalence was lower with 6% and 16%, respectively. The specificity of both markers for RA thus reached 94% and 84%, respectively. Anti-CCP aAbs were found to be elevated in inflammatory and also in non-inflammatory rheumatic diseases in the same proportion. Clinical data obtained for 36 positive patients showed that 17% developed RA within 5 years. In conclusion, anti-CCP aAbs are clearly more specific than RF for RA. Follow-up of anti-CCP aAbs-positive patients with inflammatory or non-inflammatory rheumatic diseases other than RA could be important considering the predictive value of these aAbs for the development of RA.
Similar content being viewed by others
References
Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ (1998) J Clin Invest 101:273–281
Zeng X, Ai M, Tian X, Gan X, Shi Y, Song Q, Tang F (2003) J Rheumatol 30:1451–1455
Lee DM, Schur PH (2003) Ann Rheum Dis 62:870–874
De Rycke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L, Lebeer K, Wyns B, Vincent C, Mielants H, Boullart L, Serre G, Veys EM, De Keyser F (2004) Ann Rheum Dis 63:1587–1593
Sauerland U, Becker H, Seidel M, Schotte H, Willeke P, Schorat A, Schluter B, Domschke W, Gaubitz M (2005) Ann N Y Acad Sci 1050:314–318
Zendman AJ, Vossenaar ER, van Venrooij WJ (2004) Autoimmunity 37:295–299
Bombardieri M, Alessandri C, Labbadia G, Iannuccelli C, Carlucci F, Riccieri V, Paoletti V, Valesini G (2004) Arthritis Res Ther 6:R137–141
Gottenberg JE, Mignot S, Nicaise-Rolland P, Cohen-Solal J, Aucouturier F, Goetz J, Labarre C, Meyer O, Sibilia J, Mariette X (2005) Ann Rheum Dis 64:114–117
Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ (2003) Arthritis Rheum 48:2741–2749
Dubucquoi S, Solau-Gervais E, Lefranc D, Marguerie L, Sibilia J, Goetz J, Dutoit V, Fauchais AL, Hachulla E, Flipo RM, Prin L (2004) Ann Rheum Dis 63:415–419
Avouac J, Gossec L, Dougados M (2006) Ann Rheum Dis 65:845–851
Korendowych E, Owen P, Ravindran J, Carmichael C, McHugh N (2005) Rheumatology (Oxford) 44:1056–1060
Kamali S, Polat NG, Kasapoglu E, Gul A, Ocal L, Aral O, Konice M, Badur S, Inanc M (2005) Clin Rheumatol 24:673–676
Vittecoq O, Incaurgarat B, Jouen-Beades F, Legoedec J, Letourneur O, Rolland D, Gervasi G, Menard JF, Gayet A, Fardellone P, Daragon A, Jolivet M, le Loet X, Tron F (2004) Clin Exp Immunol 135:173–180
Ingegnoli F, Galbiati V, Zeni S, Meani L, Zahalkova L, Lubatti C, Soldi A, Paresce E, Murgo A, Crapanzano C, Fantini F (2007) Clin Rheumatol 26:510–514
Vannini A, Cheung K, Fusconi M, Stammen-Vogelzangs J, Drenth JP, Dall’aglio AC, Bianchi FB, Bakker-Jonges LE, van Venrooij WJ, Pruijn GJ, Zendman AJ (2006) Ann Rheum Dis 66:511–516
Garcia-Berrocal B, Gonzalez C, Perez M, Navajo JA, Moreta I, Davila C, Gonzalez-Buitrago JM (2005) Clin Chim Acta 354:123–130
Cordonnier C, Meyer O, Palazzo E, de Bandt M, Elias A, Nicaise P, Haim T, Kahn MF, Chatellier G (1996) Br J Rheumatol 35:620–624
Vincent C, Serre G, Lapeyre F, Fournie B, Ayrolles C, Fournie A, Soleilhavoup JP (1989) Ann Rheum Dis 48:712–722
Saraux A, Berthelot JM, Devauchelle V, Bendaoud B, Chales G, Le Henaff C, Thorel JB, Hoang S, Jousse S, Baron D, Le Goff P, Youinou P (2003) J Rheumatol 30:2535–2539
von Essen R, Kurki P, Isomaki H, Okubo S, Kautiainen H, Aho K (1993) Scand J Rheumatol 22:267–272
Nell V, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, Smolen JS, Steiner G (2005) Ann Rheum Dis 64:1731–1736
Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R (2001) Clin Chem 47:1089–1093
Herold M, Boeser V, Russe E, Klotz W (2005) Clin Dev Immunol 12:131–135
van Venrooij WJ, Hazes JM, Visser H (2002) Neth J Med 60:383–388
Vasishta A (2002) Am Clin Lab 21:34–36
Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA (2002) J Rheumatol 29:2074–2076
Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA (2004) Arthritis Rheum 50:380–386
Raza K, Breese M, Nightingale P, Kumar K, Potter T, Carruthers DM, Situnayake D, Gordon C, Buckley CD, Salmon M, Kitas GD (2005) J Rheumatol 32:231–238
van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes RE, Huizinga TW (2004) Arthritis Rheum 50:709–715
Acknowledgments
The authors gratefully thank all the clinicians of the Departments of Rheumatology (Angers, Créteil, Dijon, Lyon, Marseille, Montpellier, Paris and Strasbourg) for providing the clinical diagnosis of the non-RA patients and Nina Crowte for language revision.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fabien, N., Olsson, NO., Goetz, J. et al. Prevalence of Autoantibodies to Cyclic Citrullinated Peptide in Patients with Rheumatic Diseases other than Rheumatoid Arthritis: A French Multicenter Study. Clinic Rev Allerg Immunol 34, 40–44 (2008). https://doi.org/10.1007/s12016-008-8073-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-008-8073-2